Biopharma Business

Tag "Boehringer Ingelheim"

New technology could dramatically shorten diagnosis time of stroke patients

    New technology could dramatically shorten diagnosis time of stroke patients

An ambitious collaboration between Brainomix, an emerging British business, and Boehringer Ingelheim, one of the world’s largest drug companies, is poised to expedite and improve treatment of stroke, the second

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements